A randomized discontinuation phase II trial of ridaforolimus in non-small cell lung cancer (NSCLC) patients with KRAS mutations Meeting Abstract
| Authors: | Riely, G. J.; Brahmer, J. R.; Planchard, D.; Crino, L.; Doebele, R. C.; Lopez, L. A. M.; Gettinger, S. N.; Schumann, C.; Li, X.; Atkins, B. M.; Ebbinghaus, S.; Rosell, R. |
| Abstract Title: | A randomized discontinuation phase II trial of ridaforolimus in non-small cell lung cancer (NSCLC) patients with KRAS mutations |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009804086 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.7531 |
| Notes: | Meeting Abstract: 7531 -- Source: Wos |
